We examine the impact of loss of U.S. patent exclusivity (LOE) on the prices and utilization of specialty drugs between … 2001 and 2007. We limit our empirical cohort to drugs commonly used to treat cancer and base our analyses on nationally … relationship between price declines and volume increases upon LOE holds among these drugs. First, we examine the extent to which …

We examine the impact of loss of U.S. patent exclusivity (LOE) on the prices and utilization of specialty drugs between … 2001 and 2007. We limit our empirical cohort to drugs commonly used to treat cancer and base our analyses on nationally … relationship between price declines and volume increases upon LOE holds among these drugs. First, we examine the extent to which …

crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …

, off-patent and generic drug prices are at least four times higher in the United States than in comparable English …-speaking high income countries. With five or more competitors, off-patent drug prices are similar or lower. Our analysis shows that …